Login / Signup

Response to: The use of low-dose quetiapine does not necessarily increase the risk of major adverse cardiovascular events.

Mikkel HojlundKjeld AndersenMartin Thomsen ErnstChristoph U CorrellNina Sahlertz Kristiansen
Published in: Acta neuropsychiatrica (2023)
Keyphrases
  • cardiovascular events
  • low dose
  • coronary artery disease
  • cardiovascular disease
  • high dose
  • adverse drug
  • type diabetes
  • emergency department
  • electronic health record